CODX stock extends gains on monkeypox test development (NASDAQ:CODX)
seekingalpha.com
finance
2022-05-27 19:08:21

Bill Oxford/iStock via Getty Images The shares of Co-Diagnostics (NASDAQ:CODX) are trading higher for the third straight session on Friday in solidarity with makers of monkeypox vaccines and therapeutics after molecular diagnostics company announced its contribution to address the virus outbreak. Co-Diagnostics (CODX) said Thursday that it completed the principal design work for a PCR-based test targeted at the virus. 'â€¦.We look forward to eventually making this test available in affected regions as needed to help slow the spread of the virus through early and accurate detection," Chief Executive Dwight Egan said.
